Annual Total Liabilities
$28.39 M
-$9.60 M-25.26%
December 31, 2022
Summary
- As of February 10, 2025, ACER annual total liabilities is $28.39 million, with the most recent change of -$9.60 million (-25.26%) on December 31, 2022.
- During the last 3 years, ACER annual total liabilities has risen by +$25.29 million (+817.08%).
Performance
ACER Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$47.89 M
+$6.11 M+14.62%
June 30, 2023
Summary
- As of February 10, 2025, ACER quarterly total liabilities is $47.89 million, with the most recent change of +$6.11 million (+14.62%) on June 30, 2023.
- Over the past year, ACER quarterly total liabilities has increased by +$15.87 million (+49.55%).
Performance
ACER Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ACER Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.3% | +49.5% |
| 3 y3 years | +817.1% | +1240.5% |
| 5 y5 years | +1296.1% | +1653.2% |
ACER Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.3% | at low | at high | -42.5% |
| 5 y | 5-year | -25.3% | -89.1% | at high | -95.7% |
| alltime | all time | -25.3% | -98.9% | at high | -99.7% |
Acer Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $47.89 M(+14.6%) |
| Mar 2023 | - | $41.79 M(+47.2%) |
| Dec 2022 | $28.39 M(-25.3%) | $28.39 M(+3.1%) |
| Sep 2022 | - | $27.53 M(-14.0%) |
| Jun 2022 | - | $32.03 M(-23.0%) |
| Mar 2022 | - | $41.57 M(+9.5%) |
| Dec 2021 | $37.98 M(+494.4%) | $37.98 M(+25.0%) |
| Sep 2021 | - | $30.39 M(-5.7%) |
| Jun 2021 | - | $32.21 M(-5.6%) |
| Mar 2021 | - | $34.10 M(+433.7%) |
| Dec 2020 | $6.39 M(+106.4%) | $6.39 M(+31.4%) |
| Sep 2020 | - | $4.86 M(+36.1%) |
| Jun 2020 | - | $3.57 M(+74.2%) |
| Mar 2020 | - | $2.05 M(-33.7%) |
| Dec 2019 | $3.10 M(-44.5%) | $3.10 M(+15.6%) |
| Sep 2019 | - | $2.68 M(-49.0%) |
| Jun 2019 | - | $5.25 M(+62.5%) |
| Mar 2019 | - | $3.23 M(-42.1%) |
| Dec 2018 | $5.58 M(+174.5%) | $5.58 M(+158.9%) |
| Sep 2018 | - | $2.15 M(-21.1%) |
| Jun 2018 | - | $2.73 M(+10.2%) |
| Mar 2018 | - | $2.48 M(+21.9%) |
| Dec 2017 | $2.03 M(+75.2%) | $2.03 M(-9.7%) |
| Sep 2017 | - | $2.25 M(+510.8%) |
| Jun 2017 | - | $368.50 K(-55.0%) |
| Mar 2017 | - | $818.30 K(-29.5%) |
| Dec 2016 | $1.16 M(-75.8%) | $1.16 M(-59.2%) |
| Sep 2016 | - | $2.85 M(-19.2%) |
| Jun 2016 | - | $3.52 M(-12.9%) |
| Mar 2016 | - | $4.04 M(-15.8%) |
| Dec 2015 | $4.80 M(+10.0%) | $4.80 M(-15.6%) |
| Sep 2015 | - | $5.69 M(-11.2%) |
| Jun 2015 | - | $6.41 M(-14.7%) |
| Mar 2015 | - | $7.51 M(+72.1%) |
| Dec 2014 | $4.36 M(-22.9%) | $4.36 M(-12.7%) |
| Sep 2014 | - | $5.00 M(-9.8%) |
| Jun 2014 | - | $5.54 M(+4.0%) |
| Mar 2014 | - | $5.33 M(-5.9%) |
| Dec 2013 | $5.66 M(+348.4%) | $5.66 M(-6.4%) |
| Sep 2013 | - | $6.05 M(-17.3%) |
| Jun 2013 | - | $7.32 M(+5.8%) |
| Mar 2013 | - | $6.92 M(+447.9%) |
| Dec 2012 | $1.26 M(+18.2%) | $1.26 M(-65.5%) |
| Sep 2012 | - | $3.66 M(+302.8%) |
| Jun 2012 | - | $908.50 K(-55.6%) |
| Mar 2012 | - | $2.05 M(+91.7%) |
| Dec 2011 | $1.07 M | $1.07 M(+46.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $730.50 K(-3.2%) |
| Jun 2011 | - | $754.80 K(-28.8%) |
| Mar 2011 | - | $1.06 M(+42.3%) |
| Dec 2010 | $745.30 K(-61.7%) | $745.30 K(-4.9%) |
| Sep 2010 | - | $783.30 K(-14.0%) |
| Jun 2010 | - | $910.30 K(-56.2%) |
| Mar 2010 | - | $2.08 M(+6.8%) |
| Dec 2009 | $1.94 M(+92.6%) | $1.94 M(-6.5%) |
| Sep 2009 | - | $2.08 M(+9.1%) |
| Jun 2009 | - | $1.91 M(+14.4%) |
| Mar 2009 | - | $1.67 M(+65.2%) |
| Dec 2008 | $1.01 M(-54.9%) | $1.01 M(-53.8%) |
| Sep 2008 | - | $2.18 M(+14.0%) |
| Jun 2008 | - | $1.92 M(-4.7%) |
| Mar 2008 | - | $2.01 M(-10.2%) |
| Dec 2007 | $2.24 M(-76.2%) | $2.24 M(-0.7%) |
| Sep 2007 | - | $2.25 M(-43.3%) |
| Jun 2007 | - | $3.98 M(+17.5%) |
| Mar 2007 | - | $3.38 M(-63.9%) |
| Dec 2006 | $9.38 M(+2.1%) | $9.38 M(-10.7%) |
| Sep 2006 | - | $10.51 M(-19.0%) |
| Jun 2006 | - | $12.98 M(+449.2%) |
| Mar 2006 | - | $2.36 M(-74.3%) |
| Dec 2005 | $9.19 M(+88.2%) | $9.19 M(+303.8%) |
| Sep 2005 | - | $2.28 M(-7.2%) |
| Jun 2005 | - | $2.45 M(-54.5%) |
| Mar 2005 | - | $5.39 M(+10.5%) |
| Dec 2004 | $4.88 M(+309.7%) | $4.88 M(+571.4%) |
| Sep 2004 | - | $727.30 K(+110.9%) |
| Jun 2004 | - | $344.80 K(+142.1%) |
| Mar 2004 | - | $142.40 K(-77.0%) |
| Dec 2003 | - | $618.40 K(-48.1%) |
| Sep 2003 | $1.19 M(+3.2%) | $1.19 M(-7.5%) |
| Jun 2003 | - | $1.29 M(+3.3%) |
| Mar 2003 | - | $1.25 M(+3.7%) |
| Dec 2002 | - | $1.20 M(+4.2%) |
| Sep 2002 | $1.15 M(+15.0%) | $1.15 M(+0.6%) |
| Jun 2002 | - | $1.15 M(+4.0%) |
| Mar 2002 | - | $1.10 M(+10.0%) |
| Sep 2001 | $1.00 M(+16.3%) | $1.00 M(+3.8%) |
| Jun 2001 | - | $967.50 K(+1.8%) |
| Mar 2001 | - | $950.00 K(+0.6%) |
| Dec 2000 | - | $944.40 K(+9.4%) |
| Sep 2000 | $863.20 K(+168.2%) | $863.20 K(+6.3%) |
| Jun 2000 | - | $811.80 K(+32.7%) |
| Mar 2000 | - | $611.70 K(+18.4%) |
| Dec 1999 | - | $516.80 K(+60.5%) |
| Sep 1999 | $321.90 K | $321.90 K |
FAQ
- What is Acer Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Acer Therapeutics?
- What is Acer Therapeutics annual total liabilities year-on-year change?
- What is Acer Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Acer Therapeutics?
- What is Acer Therapeutics quarterly total liabilities year-on-year change?
What is Acer Therapeutics annual total liabilities?
The current annual total liabilities of ACER is $28.39 M
What is the all time high annual total liabilities for Acer Therapeutics?
Acer Therapeutics all-time high annual total liabilities is $37.98 M
What is Acer Therapeutics annual total liabilities year-on-year change?
Over the past year, ACER annual total liabilities has changed by -$9.60 M (-25.26%)
What is Acer Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ACER is $47.89 M
What is the all time high quarterly total liabilities for Acer Therapeutics?
Acer Therapeutics all-time high quarterly total liabilities is $47.89 M
What is Acer Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ACER quarterly total liabilities has changed by +$15.87 M (+49.55%)